NovoCure Limited (NASDAQ:NVCR – Get Rating) has earned a consensus recommendation of “Hold” from the eleven analysts that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price objective […]
NovoCure Limited (NASDAQ:NVCR – Get Rating) insider Pritesh Shah sold 5,294 shares of the business’s stock in a transaction dated Monday, March 7th. The shares were sold at an average price of $69.55, for a total transaction of $368,197.70. The sale was disclosed in a filing with the SEC, which can be accessed through this […]
Novocure (NASDAQ: NVCR) announced today it will participate in two upcoming investor conferences. William Doyle, Novocure's Executive Chairman, and Ashley Cordova, Novocure's Chief Financial Officer